Learn How to Identify Functional QEEG Neuromarkers for Diagnosing Mental Illness
Antonio Martins-Mourao, PhD., Ch. Clin Psych.
April 9, 2019
QEEG-brain mapping enables the identification of neuromarkers for diagnosing mental illness. It also informs the design of personalised neurofeedback protocols and provides patients unprecedented level of information about their condition, with significant impact on therapeutic involvement. None of the above seems possible with DSM-based diagnoses that rely on the subjective classification of symptoms and behaviours and provide no information about brain network impairments. In this hands-on workshop I will share 20+ years of frontline clinical experience to guide participants through the steps used to: (1) record, de-artifact and interpret 19-channel QEEG data, (2) identify precise functional neuromarkers for a range of mental illness and neurological conditions, such as depression, OCD, PTSD, autism, and many others, (3) explore independent component analysis to estimate sub-cortical (in-depth) sources of electrical activity in the brain and, finally (4) design personalised neurofeedback protocols with unprecedented precision, enabling faster results for your clients.
By the end of this workshop you will have been introduced to:
- 19-channel QEEG data recording and de-artifacting;
- functional neuromarkers interpretation;
- the power of independent component analysis (ICA) to estimate sub-cortical sources of neural activity;
- the step-by-step used in personalised neurofeedback protocols design, based on ICA.
About Dr. Antonio Martins-Mourao
Dr Martins-Mourao is a neuro-psychophysiologist (PhD, University of London) and clinical director at londonScientific Neurotherapy. He has lectured Psychophysiology & Mental Health at the Open University (UK), where he also directed the QEEG & Brain Research Lab, dedicated to the research of neuromarkers for anxiety disorders (OCD and PTSD). Dr Martins-Mourao is a regular presenter of QEEG-Neuromodulation workshops in the UK, France, Italy, Spain and Brazil, where he brings together innovative pedagogical design, 20+ years of frontline clinical experience and the use of QEEG brain mapping for the analysis and interpretation of neuromarkers for a range of mental illness conditions. He is particularly interested on the Gut-Brain axis and the analysis and interpretation of inflammation Neuromarkers – and their effect on mental illness. He is an Associate Fellow and a chartered member of the clinical division of the British Psychological Society (BPS), a member of the board of directors of the Foundation for Neuromodulation & Neurofeedback Research (FNNR) and co-author of the book Alpha-Theta Neurofeedback in the 21st Century: A Handbook for Clinicians and Researchers.